Back to ROYCE & ASSOCIATES LP ROYCE & ASSOCIATES LP

HAHAE
Showing 8 of 27 quarters

Position history for ROYCE & ASSOCIATES LPROYCE & ASSOCIATES LP's holdings in HAEMONETICS CORP MASS

ROYCE & ASSOCIATES LP holds 71,475 shares of HAE (HAEMONETICS CORP MASS), worth $5.4M as of 2026-Q2. HAE represents 0.0% of ROYCE & ASSOCIATES LP's portfolio.

Current Value

$5.4M

Current Shares

71,475

Total Value Change

-$91.9M

Total Shares Change

-1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
71,475
0.0%
$5.4M0.0%$75.00
0
2026-Q1
Unchanged
71,475
0.0%
$4M0.0%$65.63
0
2025-Q4
Decreased
71,475
-89.8%
$5.7M0.1%$80.98
0
2025-Q3
Decreased
701,242
-44.8%
$34.2M0.3%$48.12
0
2025-Q2
Increased
1.3M
+9.4%
$94.8M1.0%$73.80
46
2025-Q1
Increased
1.2M
+0.7%
$73.8M0.8%$63.19
42
2024-Q4
Decreased
1.2M
-4.7%
$90M0.8%$76.60
0
2024-Q3
Increased
1.2M
+2.6%
$97.3M0.9%$79.80
43

Other major holders of HAE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used